SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for CMOPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 34.02M
December 31, 2025 30.19M
June 30, 2025 37.18M
December 31, 2024 39.25M
June 30, 2024 39.42M
December 31, 2023 32.37M
June 30, 2023 20.99M
December 31, 2022 20.94M
June 30, 2022 14.16M
December 31, 2021 12.46M
June 30, 2021 20.72M
December 31, 2020 21.37M
June 30, 2020 26.19M
December 31, 2019 39.62M
June 30, 2019 47.91M
December 31, 2018 59.99M
June 30, 2018 64.51M
December 31, 2017 52.46M
June 30, 2017 33.19M
December 31, 2016 17.30M
Date Value
June 30, 2016 11.15M
December 31, 2015 25.46M
June 30, 2015 33.51M
December 31, 2014 22.06M
June 30, 2014 14.09M
December 31, 2013 10.19M
June 30, 2013 9.288M
December 31, 2012 7.688M
June 30, 2012 8.282M
December 31, 2011 7.918M
June 30, 2011 8.227M
December 31, 2010 8.228M
June 30, 2010 11.78M
December 31, 2009 11.31M
June 30, 2009 7.589M
December 31, 2008 8.122M
June 30, 2008 4.586M
December 31, 2007 0.4893M
June 30, 2007 0.00
December 31, 2006 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc 191.46M
Jazz Pharmaceuticals Plc 1.679B
Perrigo Co. Plc 997.20M
GH Research Plc 24.75M
Alkermes Plc 841.17M